VAXIGRIP

This brand name is authorized in Brazil, Estonia, Israel, Lithuania, Singapore, Tunisia, South Africa

Active ingredients

The drug VAXIGRIP contains one active pharmaceutical ingredient (API):

1 Influenza, inactivated, split virus

Read about Influenza, inactivated, split virus

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BB02	Influenza, purified antigen	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502821603157419, 502821604153417, 576720020055317, 576720020055417, 576720020055517
Country: EE	Ravimiamet	Identifier(s): 1115323, 1287907, 1287918, 1287929
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 1173
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1024943, 1026495, 1026496, 1026497, 1033589, 1033590, 1033591, 1033592
Country: SG	Health Sciences Authority	Identifier(s): 10545P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 12063011
Country: ZA	Health Products Regulatory Authority	Identifier(s): T/30.1/674